These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10544941)

  • 1. Poor recovery and short survival of infused factor X in a case of acquired factor X deficiency and amyloidosis.
    Duncan EM; Cole J; Clarkson AR; Lloyd JV
    Thromb Haemost; 1999 Oct; 82(4):1375-6. PubMed ID: 10544941
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosis.
    Schwarzinger I; Stain-Kos M; Bettelheim P; Pabinger I; Kyrle P; Kalhs P; Kapiotis S; Jäger U; Lechner K
    Thromb Haemost; 1992 Dec; 68(6):648-51. PubMed ID: 1287879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis.
    Mahmood S; Blundell J; Drebes A; Hawkins PN; Wechalekar AD
    Blood; 2014 May; 123(18):2899-900. PubMed ID: 24786460
    [No Abstract]   [Full Text] [Related]  

  • 4. Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy.
    Camoriano JK; Greipp PR; Bayer GK; Bowie EJ
    N Engl J Med; 1987 Apr; 316(18):1133-5. PubMed ID: 3574359
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired factor X deficiency and amyloidosis treated with melphalan and prednisone.
    Levin M; Chokas W
    N Engl J Med; 1987 Oct; 317(18):1155-6. PubMed ID: 3657882
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.
    Enjeti AK; Walsh M; Seldon M
    Haemophilia; 2005 Sep; 11(5):535-8. PubMed ID: 16128899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired factor X deficiency associated with A.L.type amyloidosis. A case report].
    Jeribi M; Hachicha J; Ben Hamida M; Gouiaa R; Jlidi R; Jarraya A
    Tunis Med; 1996 Feb; 74(2):97-100. PubMed ID: 9507305
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolated factor X deficiency in amyloidosis. Case report and review of the literature.
    Van Dam FE; de Pauw BE; Schutjes CP; Veuger AJ
    Neth J Med; 1975; 18(4):129-34. PubMed ID: 1101084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acquired factor X deficiency in primary amyloidosis].
    Estivill X; Zurita L; Santesmasses A; Piera J; Segura J; Félez J
    Med Clin (Barc); 1984 Jun; 83(5):223. PubMed ID: 6482586
    [No Abstract]   [Full Text] [Related]  

  • 10. Acquired combined factor X and XII deficiency with isolated bleeding complications in a patient with AL amyloidosis.
    Wiest R; Klouche M; Härle P; Bross K; Blaszyk H; Fischereder M; Reng CM
    Ann Hematol; 2005 Mar; 84(3):196-9. PubMed ID: 15551096
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary amyloidosis associated to severe factor X deficiency].
    Pérez Martínez J; Llamas F; López Montes A; Massó P; Poblet E; López Rubio E; Gallego E; Gómez Roldán C
    Nefrologia; 2004; 24(5):493-8. PubMed ID: 15648909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.
    Breems DA; Sonneveld P; de Man RA; Leebeek FW
    Eur J Haematol; 2004 Mar; 72(3):181-5. PubMed ID: 14962236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined deficiency of factor VII and X in a patient with multiple myeloma and amyloidosis].
    Elezović I; Rolović Z; Bukanović R; Bosković D; Milosević N; Marković J; Krasojević I; Blagojević R
    Srp Arh Celok Lek; 1987 Apr; 115(4):449-60. PubMed ID: 3270180
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemarthrosis disclosing factor X deficiency in primary amyloidosis].
    Hamidou M; Bani-Sadr F; Ficks-Sigaud M; Moreau A; Jego P; Lalande S; Grolleau JY
    Rev Rhum Ed Fr; 1993 May; 60(5):373-4. PubMed ID: 8167648
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor X deficiency and systemic amyloidosis.
    Glenner GG
    N Engl J Med; 1977 Jul; 297(2):108-9. PubMed ID: 405589
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acquired deficit in factor X associated with amyloidosis. One case (author's transl)].
    Maroy B; Mottier D; Saleun JP; Bergeret G
    Nouv Presse Med; 1978 Nov; 7(38):3441-2. PubMed ID: 740523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of primary hepatic amyloidosis with factor X deficiency].
    Dong MK; Cui Y; Xia H; Zhou LY; Sun WG; Li CL; Zhang HW; Ji M; Li XO
    Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):684. PubMed ID: 16995985
    [No Abstract]   [Full Text] [Related]  

  • 18. Report on a disease-adapted treatment in a patient with severe factor X deficiency resulting from a homozygous factor X gene mutation.
    Gerhardt A; Araba F; Scharf RE; Zotz RB
    Thromb Haemost; 2008 Jan; 99(1):238-9. PubMed ID: 18217161
    [No Abstract]   [Full Text] [Related]  

  • 19. [Familial amyloidosis of AL type and factor X deficiency. The valve of long-term colchicine administration].
    De Wazières B; Fest T; Humbert P; Vuitton D; Dupond JL
    Ann Med Interne (Paris); 1990; 141(4):388-90. PubMed ID: 2240953
    [No Abstract]   [Full Text] [Related]  

  • 20. Resolution of acquired factor X deficiency with amyloidosis secondary to plasma cell dyscrasia.
    Mohri H
    Am J Hematol; 2004 Dec; 77(4):421-2. PubMed ID: 15551292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.